Faculty of Pharmacy, Medical University of Gdansk, Al. Gen. J. Hallera 107, 80-416 Gdansk, Poland.
Faculty of Medicine, Medical University of Gdansk, Debinki 7, 80-211 Gdansk, Poland.
Pharmaceuticals (Basel). 2016 May 25;9(2):30. doi: 10.3390/ph9020030.
Staphylococcus aureus (SA) colonizes the vast majority of patients with atopic dermatitis (AD). Its resistance to antibiotics and ability to form biofilms are the main origins of therapeutic complications. Endogenous antimicrobial peptides (AMPs) exhibit strong activity against SA, including antibiotic resistant strains as well as bacteria existing in biofilm form. The purpose of the present work was to determine the antistaphylococcal activity of two amphibian peptides against SA isolated from patients with AD. The AMPs demonstrated permanent activity towards strains exposed to sublethal concentrations of the compounds and significantly stronger antibiofilm activity in comparison to that of conventional antimicrobials. The results suggest the potential application of amphibian AMPs as promising antistaphylococcal agents for the management of skin infections.
金黄色葡萄球菌(SA)定植于绝大多数特应性皮炎(AD)患者。其对抗生素的耐药性和形成生物膜的能力是治疗并发症的主要来源。内源性抗菌肽(AMPs)对 SA 具有很强的活性,包括对抗生素耐药菌株以及以生物膜形式存在的细菌。本工作旨在确定两种来自两栖动物的肽类物质对从 AD 患者中分离出的 SA 的抗葡萄球菌活性。这些 AMPs 对暴露于化合物亚致死浓度下的菌株具有持久的活性,并且与传统抗生素相比,其抗生物膜活性显著增强。结果表明,两栖动物 AMPs 具有作为有前途的抗葡萄球菌药物,可用于治疗皮肤感染。